| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/01/2011 | CA2446994C Prostanoic acid derivatives as agents for lowering intraocular pressure |
| 02/01/2011 | CA2446386C 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 02/01/2011 | CA2342133C Ophthalmic formulations |
| 02/01/2011 | CA2313653C Prevention and/or treatment of allergic conditions |
| 01/27/2011 | WO2011011753A1 Manufacture of factor h (fh) and fh-derivatives from plasma |
| 01/27/2011 | WO2011011607A1 Composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome |
| 01/27/2011 | WO2011011123A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| 01/27/2011 | WO2011010399A1 Corneal endothelial cell proliferation promoter |
| 01/27/2011 | WO2011010080A1 Inhibitor of inflammatory conditions |
| 01/27/2011 | WO2010138210A8 Methods of saponifying xanthophyll esters and isolating xanthophylls |
| 01/27/2011 | WO2010130462A3 Phosphate-free pharmaceutical composition for the treatment of glaucoma |
| 01/27/2011 | US20110021974 Retinitis pigmentosa treatment and prophalaxis |
| 01/27/2011 | US20110021766 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 01/27/2011 | US20110021618 Methods of treating fibrotic disorders |
| 01/27/2011 | US20110021605 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 01/27/2011 | US20110021595 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 01/27/2011 | US20110021590 Aminopyrrolidinone derivatives and uses thereof |
| 01/27/2011 | US20110021526 Pharmaceutical Composition for Treatment of Diabetic Complications |
| 01/27/2011 | US20110021525 P70S6 Kinase Modulators and Method of Use |
| 01/27/2011 | US20110021485 Indole derivatives and their metal conjugates and uses thereof |
| 01/27/2011 | US20110021465 Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome |
| 01/27/2011 | US20110021462 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 01/27/2011 | US20110021432 Manufacture of factor h (fh) and fh-derivatives from plasma |
| 01/27/2011 | US20110021424 Polypeptide derived from protein a and able to bind pdgf |
| 01/27/2011 | US20110020453 Topical Formulations Comprising Ion Channel Modulators |
| 01/27/2011 | US20110020449 Methods of treating disorders of the eye and surrounding tissue with thymosin beta 4 (tb4), analogues, isoforms and other derivatives |
| 01/27/2011 | US20110020448 Pharmaceutical composition for the treatment and prevention of glaucoma |
| 01/27/2011 | US20110020346 Anti-vegf antibodies |
| 01/27/2011 | US20110020338 5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes |
| 01/27/2011 | US20110020304 Synbiotic mixture |
| 01/27/2011 | US20110020237 Compositions and Methods for Inhibiting Drusen Formation and for Diagnosing or Treating Drusen-Related Disorders |
| 01/26/2011 | EP2278010A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278009A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278008A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278004A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 01/26/2011 | EP2277899A2 Antimicrobial peptides |
| 01/26/2011 | EP2277880A1 Macrolides with VEGF transcription suppression activity |
| 01/26/2011 | EP2277535A2 Vaccine |
| 01/26/2011 | EP2277526A1 Pharmaceutical composition with tetrahydroisohumulone |
| 01/26/2011 | EP2277520A2 A pharmaceutical composition for angiotensin ii-mediated diseases |
| 01/26/2011 | EP2277516A1 Retinyl derivatives for treating ophtalmic conditions |
| 01/26/2011 | EP2276501A2 Methods and compositions for genetic and retinal disease |
| 01/26/2011 | EP2276496A1 Therapeutic modulation of ocular surface lubrication |
| 01/26/2011 | EP2276492A2 Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
| 01/26/2011 | EP2276485A1 Use of epothelone d in treating tau-associated diseases including alzheimer's disease |
| 01/26/2011 | EP2125773B1 Thiophene derivatives useful as medicaments for treating ocular hypertension |
| 01/26/2011 | EP1638936B1 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 01/26/2011 | EP1496892B1 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/26/2011 | EP1446382B1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 01/26/2011 | CN101959854A Substituted cyclopentanes having prostaglandin activity |
| 01/26/2011 | CN101959531A Agent for enhancing corneal epithelial barrier function |
| 01/26/2011 | CN101959524A 抗过敏剂 Antiallergic agent |
| 01/26/2011 | CN101959519A Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
| 01/26/2011 | CN101959514A Prophylactic or therapeutic agent for ocular disease accompanied by optic nerve disorder |
| 01/26/2011 | CN101959503A Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye |
| 01/26/2011 | CN101954028A Medicinal pillow for preventing and treating myopic eyes |
| 01/26/2011 | CN101953990A Dynawave visual rehabilitation instrument and traditional Chinese medicine compound |
| 01/26/2011 | CN101953989A Electromagnetic wave vision rehabilitation instrument and Chinese medicinal composition |
| 01/26/2011 | CN101953950A Chinese medicament for treating viral keratitis |
| 01/26/2011 | CN101953939A Chinese medicament for treating diabetic eye diseases |
| 01/26/2011 | CN101953938A Traditional Chinese medicine for treating diabetic retinopathy |
| 01/26/2011 | CN101632813B Novel traditional Chinese medicine composition for treating diabetes class eyeground haemorrhage and preparation method thereof |
| 01/26/2011 | CN101579488B Chinese medicament for treating cataract and glaucoma |
| 01/26/2011 | CN101454439B Method for culture of lactic acid bacterium having high immunomodulating activity |
| 01/26/2011 | CN101433609B Use of pharmaceutical composition in preparing medicament for preventing and treating allergic diseases |
| 01/26/2011 | CN101396533B Traditional Chinese medicine for treating acute catarrhal otitis media |
| 01/26/2011 | CN101107014B Stabilisation of glucocorticoid esters with acids |
| 01/25/2011 | US7875727 Benzimidazole vascular damaging agents |
| 01/25/2011 | US7875712 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 01/25/2011 | US7875652 Method and composition for treating pain or tinnitus aureum |
| 01/25/2011 | US7875611 Ion channel modulating compounds and uses thereof |
| 01/25/2011 | US7875608 Substituted 8-[6-amino-3pyridyl]xanthines |
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |
| 01/25/2011 | CA2496540C Stable ophthalmic solution comprising latanoprost as active ingredient |
| 01/25/2011 | CA2490141C 1-[(indol-3-yl)carbonyl]piperazine derivatives |
| 01/25/2011 | CA2476983C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma |
| 01/25/2011 | CA2468673C Compounds specific to adenosine a1 and a3 receptors and uses thereof |
| 01/25/2011 | CA2463146C Crystalline sodium salt of telmisartan and the use of same as an angiotensin antagonist |
| 01/25/2011 | CA2447765C 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
| 01/25/2011 | CA2432582C Sulfamidothienopyrimidines |
| 01/25/2011 | CA2413928C Corneal epithelial migration promoter |
| 01/25/2011 | CA2385322C A substantially cell membrane impermeable compound and use thereof |
| 01/25/2011 | CA2334200C Pyrrolo[2,3d]pyrimidine compositions and their use |
| 01/25/2011 | CA2317455C Hydroxamic and carboxylic acid derivatives |
| 01/20/2011 | WO2011008475A1 Optionally substituted 2-(arylmethyl, aryloxy or arylthio) -n- pyridin-2 -yl-aryl acetamide or 2, 2-bis (aryl) -n-pyridin-2-yl acetamide compounds as medicaments for the treatment of eye diseases |
| 01/20/2011 | WO2011007893A1 Eye drop with difluprednate for macular edema treatment |
| 01/20/2011 | WO2011007870A1 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof |
| 01/20/2011 | WO2011007755A1 Angiogenesis-regulating composition and angiogenesis regulation method |
| 01/20/2011 | WO2011007722A1 3-substituted-2-furancarboxylic acid hydrazide derivative and pharmaceutically acceptable salt thereof |
| 01/20/2011 | WO2011007633A1 Crystals of pyrroloquinolinequinone sodium salts |
| 01/20/2011 | WO2011006567A1 Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 01/20/2011 | WO2010125148A3 Methods for treating ocular conditions |
| 01/20/2011 | WO2010093209A3 Use of caveolin-1 as biomarker diagnosing wound healing ability after ophthalmological surgery and method for diagnosing wound healing ability using the same |
| 01/20/2011 | WO2010000374A8 Protein complexes and screening methods |
| 01/20/2011 | US20110016544 Methods and compositions for detecting and treating retinal diseases based on metargidin (ADAM-15) |
| 01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/20/2011 | US20110015277 Method of producing egg yolk based functional food product and products obtainable thereby |
| 01/20/2011 | US20110015271 Topical nepafenac formulations |
| 01/20/2011 | US20110015240 Thiazole derivative and use thereof as vap-1 inhibitor |
| 01/20/2011 | US20110015195 Aryl ureas with angiogenisis inhibiting activity |